共 50 条
Use of Osteobiologics for Fracture Management: The When, What, and How
被引:3
|作者:
Marmor, Meir T.
[1
]
Matz, Jacob
[1
]
McClellan, Robert Trigg
[1
]
Medam, Ramapaada
[2
]
Miclau, Theodore
[1
]
机构:
[1] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Orthopaed Trauma Inst, Dept Orthopaed Surg, San Francisco, CA 94143 USA
[2] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA
来源:
关键词:
Fracture;
Bone;
Healing;
Osteobiologics;
Synthetic;
Natural;
DEMINERALIZED BONE-MATRIX;
CALCIUM-PHOSPHATE CEMENT;
PLATELET-RICH PLASMA;
PROXIMAL HUMERAL FRACTURES;
OPEN TIBIAL FRACTURES;
GROWTH-FACTOR;
INTERNAL-FIXATION;
DELAYED UNION;
DOUBLE-BLIND;
ILIAC CREST;
D O I:
10.1016/j.injury.2021.01.030
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Osteobiologics are defined as a group of natural and synthetic materials used to augment bone healing. The selection of the most appropriate osteobiologic from the growing list of available options can be a challenging task. In selecting a material, surgeons should weigh a variety of considerations, including the indication for their use (the when), the most suitable substance (the what), and the correct mode of application (the how). This summary reviews these considerations and seeks to provide the surgeon with a basis for informed clinical evidence-based decision-making in their choice of a successful option. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:S35 / S43
页数:9
相关论文